May 11, 2023
The U.S. Drug Enforcement Administration (DEA) is extending the ability for physicians to prescribe controlled substances based on telehealth visits through November 11, 2023. This method had been set to expire when the COVID-19 Public Health Emergency ended today (May 11).
On March 1, the DEA and the Department of Health and Human Services (HHS), sent out notices of proposed rulemakings (NPRMs) to generate feedback on proposals to continue allowing the prescribing of controlled medications via virtual visits with patients. More than 38,000 public comments came in.
“These medications, including those used to treat opioid use disorder, are a vital form of care for millions of Americans who have come to rely on safe and effective telemedicine appointments,” said the AMA in a statement. “Patients being treated with these medications often have challenges securing and traveling to in-person appointments.”
October 9, 2025
The MMA is partnering with Hennepin Healthcare to offer an in-person session on “Supporting Patients, Families, and Professionals in the Aftermath of Crisis” on October 21 from 6 to 8 pm in Room RL110 at the HCMC Red Building, 730 South 8th Street, in Minneapolis.
October 9, 2025
The MMA, in partnership with the Wisconsin Medical Society, will lead a panel discussion titled "The Role of Medical and Professional Societies in Supporting Clinicians and Community Health" at the Transforming Community and Rural Healthcare 2025: Bold Innovation and Partnerships symposium, to be held on October 27-28, at the Mayo Civic Center in Rochester.
October 2, 2025
The federal government shutdown will affect the Minnesota healthcare system in several important ways.